Department Of Health And Human Services

Ophthalmic and Topical Dosage Form New Animal Drugs; Miconazole, Polymixin B, and Prednisolone Suspension

January 29, 2010 - 75 FR 4692 - RIN: - Download Full Notice: Text | PDF

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Janssen Pharmaceutica NV. The NADA provides for use of miconazole nitrate, polymixin B sulfate, and prednisolone acetate for the treatment of otitis externa in dogs.

Agency Contact: Melanie R. Berson, Center for Veterinary Medicine (HFV-110), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-276-8337, e-mail: melanie.berson@fda.hhs.gov.

This rule is final. Its effective date is January 29, 2010.





Image 01 Image 02 Image 03 Image 04 Image 05 Image 06 Image 07 Image 08